|
||||||||||||
 |
||||||||||||
|
||||||||||||
Top Stories
Immunize.org Pages and Handouts
Featured Resources
Notable Publications
Top Stories
“Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines—United States, 2022” published in MMWR describing ACIP votes on September 1 and October 12, 2022
CDC published Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines—United States, 2022 on November 11 in MMWR. The recommendations described were approved by ACIP on September 1 and October 12. A portion of the summary appears below. In fall 2022, CDC recommended a bivalent mRNA COVID-19 vaccine booster dose for persons aged ≥5 years, administered ≥2 months after completing the primary series or after receipt of a monovalent booster dose. . . . Bivalent COVID-19 vaccine booster doses might improve protection against SARS-CoV-2 Omicron sublineages and, along with completion of a primary series in persons who remain unvaccinated, are important to protect against COVID-19, particularly among those persons who are at increased risk for severe illness and death. Access the MMWR article in HTML or PDF.
Roll up your sleeve! Now is the time for you, your patients, and your coworkers to be vaccinated against influenza. Early increases in seasonal influenza activity continue nationwide. High levels of activity are expanding beyond the south. CDC expects influenza activity to continue to increase and spread across the United States in its seasonal epidemic pattern. CDC’s Weekly U.S. Influenza Surveillance Report, FluView, provides a valuable snapshot of influenza activity state-by-state.
Samuel L. Katz, M.D., FAAP, who codeveloped the measles vaccine, passed away on October 31 at age 95. Dr. Katz was a world-renowned virologist and pediatrician with degrees from Dartmouth College and Harvard University. He served a medical internship at Beth Israel Hospital and completed pediatrics residency training at Massachusetts General Hospital and Boston Children’s Hospital.
National Community Pharmacists Association releases first episode of "Show Me," an online reality series following pharmacists as they start or improve vaccination programs
The National Community Pharmacists Association (NCPA) released the first episode of its new online educational reality series titled "Show Me." This series, which is sponsored by Pfizer, is styled after popular TV makeover shows and features real pharmacists who need help getting a certain aspect of their practice on track. This season the subject is vaccinations. The rest of this season’s five episodes will be released in the coming weeks on NCPA’s various internet platforms including its YouTube channel, NCPAvids, and its website. Follow @commpharmacy on social media for updates and sneak previews. Back to top
On November 4, FDA licensed a new formulation of Rotavirus Vaccine, Live, Oral (Rotarix, GSK). The new formulation is free of porcine circovirus (PCV) and comes as a liquid that does not require mixing or dilution. The single dose oral applicator increases provider convenience.
Immunize.org's Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,294 organizations, including one new facility
Immunize.org's Influenza Vaccination Honor Roll recognizes facilities that take a stand for patient safety by implementing policies for mandatory healthcare personnel influenza vaccination. There are now 1,294 organizations enrolled. Since October 19, 2022, Immunize.org welcomed one additional healthcare organization.
 Eligibility:
Spotlight: Immunize.org's "Handouts" main page provides free access to hundreds of vaccination-related handouts and fact sheets
Immunize.org's Handouts for Patients and Staff web page leads users to hundreds of free vaccination-related patient handouts and fact sheets for healthcare professionals. All items are ready to print, copy, and distribute widely.
From the main page, you can search by any of the 22 topics. Some of the most popular are:
You can also view an alphabetical listing of Immunize.org’s more than 230 ready-to-print staff educational materials and patient handouts. These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Immunize.org Pages and Handouts
Immunize.org updates two standing orders templates for administering hepatitis A vaccine—one for children and teens and one for adults
Featured Resources
Voices for Vaccines (VFV) posted a new entry in its Vax Talk podcast series: The Future of mRNA Vaccines featuring Melissa Moore, PhD, Chief Scientific Officer for Moderna. A description from the VFV web page appears below. In many ways, mRNA vaccines are a game-changer, but not an unexpected one. For this episode, we talked to one of the scientists who has been pursuing mRNA vaccines for years: Melissa Moore, Ph.D. We discuss how mRNA vaccines have changed so much for us and what the future might hold. Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety. Download Immunize.org’s free 142-page book on adult vaccination to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide).
Notable Publications
“Preferential Recommendations for Vaccines: Time for a Structured, Transparent Process” commentary published online in Vaccine
Preferential Recommendations for Vaccines: Time for a Structured Transparent Process, a commentary by Immunize.org's President and Chief Executive Officer, Kelly L. Moore, MD, MPH, and the Chief Policy and Partnerships Officer, Litjen (L.J) Tan, MS, PhD, is now posted ahead of print by Vaccine. In the commentary, the authors note: “COVID-19–Associated Hospitalizations among U.S. Infants Aged <6 Months—COVID-NET, 13 States, June 2021–August 2022” published in MMWR CDC published COVID-19–Associated Hospitalizations among U.S. Infants Aged <6 Months—COVID-NET, 13 States, June 2021–August 2022 on November 11 in MMWR. A portion of the summary appears below. Although population-based COVID-19–associated hospitalization rates among infants aged <6 months increased in the Omicron variant–predominant periods compared with the Delta variant–predominant period, indicators of the most severe disease among hospitalized infants aged <6 months did not. . . . Pregnant women should stay up to date with COVID-19 vaccination to help protect themselves and infants too young to be vaccinated. Nonpharmaceutical measures should be used to help protect infants ineligible for vaccination.
“Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response—United States, May 17–October 6, 2022” published in MMWR CDC published Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response—United States, May 17–October 6, 2022 on November 11 in MMWR. A portion of the summary appears below. CDC’s emergency response focused on surveillance, laboratory testing, medical countermeasures, and education. A total of 26,384 U.S. monkeypox cases were reported during May 17–October 6, 2022. Among 59% of persons with data on gender and recent sexual or close intimate contact, 70% reported recent male-to-male sexual contact. Black and Hispanic persons continue to be disproportionately affected. . . . Public health monkeypox prevention efforts, including vaccination, should continue to prioritize gay, bisexual, and other men who have sex with men, Black and Hispanic persons, and persons who are immunocompromised.
For more upcoming events, visit our Calendar of Events.
|
||||||||||||
|
